Evaluating the Cardiorenal Benefits of Dapagliflozin and Valsartan in Individuals with Type 2 Diabetes and Hypertension: A Retrospective Cohort Analysis

• by Zhengrong Zhou, Kaizheng Gong

• April 24, 2026

Effects of altitude and sociodemographic factors on cardiometabolic disorders in the southwestern plateau areas of China

• by Nan Zhang, Wenlong Zhu, Yu Xia, Lin Duo, Zhiling Luo, Mingjing Tang, Da Zhu

• May 15, 2026

Grip Strength Plus Waist Size May Flag Risk T2D Risk

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.

• by Andrea Surnit

• May 20, 2026

• 5 min

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

• by Kathryn Wighton

• May 6, 2026

• 4 min